| Cat.#: 28147 |
| Product Name: Anti-CLEC4C (Litifilimab) Monoclonal Antibody |
| Synonyms: BDCA-2;CD303 |
| Description: Anti-CLEC4C (litifilimab ) Monoclonal Antibody |
| Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Applications: ELISA; Flow Cyt |
| Recommended Dilutions: ELISA 1:5000-10000; Flow Cyt 1:100 |
| Host Species: Humanized |
| Isotype: IgG1(E239D, M241L) |
| Purification: Purified from cell culture supernatant by affinity chromatography |
| Species Reactivity: Human CLEC4C |
| Constituents: Lyophilized from sterile PBS, pH 7.4. 5 % – 8% trehalose is added as protectants before lyophilization. |
| Storage & Shipping: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). |
Figure 1. ELISA plate pre-coated by 2 µg/mL (100 µl/well) Human CLEC4C Protein, hFc Tag (11544) can bind Anti-CLEC4C (litifilimab biosimilar) mAb (28147) in a linear range of 0.64-80.00 ng/mL. In order to specifically detect 28147, mouse anti-human Fab-specific antibody was used as detection antibody. | 
Figure 2. Flow cytometry analysis with 1 µg/mL Anti-CLEC4C (litifilimab biosimilar) mAb (28147) on Expi293 cells transfected with Human CLEC4C protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram). |
|
